Total Revenue of $20.0 Million, Up 83% Year over Year
Membership of 12.6 Million, Up 56% Year over Year
Visits of 117,213, Up 89% Year over Year
Teladoc, Inc. (NYSE: TDOC), the first and largest telehealth platform in
the United States, today announced results for its third quarter ended
September 30, 2015.
Jason Gorevic, Chief Executive of Officer of Teladoc, commented, “Our
third quarter results show solid growth across all of our metrics. Visit
growth continued to see strong momentum and for the eleventh consecutive
quarter, our visit growth exceeded our membership growth, which
demonstrates that our impactful consumer engagement strategies are
working and driving utilization. In terms of our revenue streams, this
quarter saw an increase in revenue from visit fees, as well as from
subscription fees. Importantly, our PMPM fees increased both
sequentially and year over year.”
Mr. Gorevic continued, “New account wins continue at a record pace, as
we’ve already signed over 500 new clients across all of our market
segments during this selling season. We are executing on our business
plan, our sales pipeline is full, and we remain the leader in this
exciting telehealth market.”
Financial Performance for the Three Months
Ended September 30, 2015
All comparisons, unless otherwise noted, are to the quarter ended
September 30, 2014.
-
Total revenue was $20.0 million, an increase of 83%. Revenue from
subscription access fees and visit fees was $17.0 million and $3.0
million, respectively, an increase of 78% and 122%, respectively.
-
Total membership was 12.6 million, compared to 8.1 million, an
increase of 56%.
-
Total visits were 117,213, compared to 61,929, an increase of 89%.
-
Gross margin was 78%, compared to a gross margin of 80%.
-
Operating loss was $13.2 million, compared to an operating loss of
$4.5 million.
-
Net loss per basic and diluted share was $0.37, compared to a net loss
per share of $2.68.
-
EBITDA was a loss of $11.1 million, compared to a loss of $3.2 million.
-
Adjusted EBITDA was a loss of $10.4 million, compared to a loss of
$3.1 million.
-
Total cash, cash equivalents and short-term investments in marketable
securities were $152.0 million at the end of the third quarter of 2015.
A reconciliation of GAAP to non-GAAP results has been provided in this
press release in the accompanying tables. An explanation of these
measures is also included below under the heading “Non-GAAP Financial
Measures”.
Business Outlook
Fourth Quarter 2015 Guidance: Revenue for the company’s fourth
quarter 2015 is expected to be in the range of $21 million to $22
million. EBITDA is expected to be in the range of a loss of $13 million
to a loss of $14 million. Adjusted EBITDA is expected to be in the range
of a loss of $12.3 million to a loss of $13.3 million. Total visits are
projected to be between 150,000 and 160,000. Fourth quarter net loss per
share, based on 38.4 million weighted average shares outstanding, of
between $(0.41) and $(0.43).
Full Year 2015 Guidance: Revenue for the company’s full year 2015
is expected to be in the range of $75.5 million to $76.5 million. EBITDA
is expected to be in the range of a loss of $51 million to a loss of $52
million. Adjusted EBITDA is expected to be in the range of a loss of $48
million to a loss of $49 million. Total visits for the full year are
projected to be between 540,000 and 550,000. The 2015 net loss per
share, based on 19.9 million weighted average shares outstanding, of
between $(2.95) and $(3.00).
Quarterly Conference Call
Teladoc will host a conference call to discuss its third quarter 2015
results today, November 2, 2015, at 5:00 p.m. EST. Interested parties
may listen to a live broadcast of the conference call by dialing
877-201-0168 or 647-788-4901 for international callers, and referencing
participant code 56728128. A live webcast of the conference call will be
available on the investor relations section of the company’s website and
an audio file of the call will also be archived for 90 days at ir.teladoc.com.
After the conference call, a replay will be available until November 16,
2015 and can be accessed by dialing 855-859-2056 or 404-537-3406 for
international callers, and referencing participant code 56728128.
About Teladoc
Teladoc, Inc. (NYSE: TDOC) is the nation’s first and largest telehealth
platform, delivering on-demand healthcare anytime, from almost anywhere via
mobile devices, the internet, secure video and phone. More than 12.5
million U.S. members are connected to Teladoc’s network of over 2,650
board-certified, state-licensed physicians and behavioral health
professionals who provide care for a wide range of non-emergency
conditions. With a median response time of less than 10 minutes, Teladoc
physicians will perform approximately 550,000 telehealth visits in 2015.
Teladoc and its physicians consistently earn a 95 percent member
satisfaction rating or better, and Teladoc is the only telehealth
company to be certified by the National Committee for Quality Assurance
(NCQA) for its physician credentialing process.
Recognized in June 2015 by MIT Technology Review as “One of
the 50 Smartest Companies,” Teladoc works with health plans, employers,
organizations and individuals to provide access to affordable,
high-quality healthcare on-demand. Teladoc is transforming the access,
cost and quality dynamics of healthcare delivery. For more information,
please visit teladoc.com,
twitter.com/teladoc,
facebook.com/teladoc
or linkedin.com/teladoc.
Cautionary Note Regarding Forward-Looking Statements
This press release contains “forward-looking statements” within the
meaning of the safe harbor provisions of the U.S. Private Securities
Litigation Reform Act of 1995. Forward-looking statements can be
identified by words such as: “anticipate,” “intend,” “plan,” “believe,”
“project,” “estimate,” “expect,” “may,” “should,” “will” and similar
references to future periods. Examples of forward-looking statements
include, among others, statements we make regarding future revenues,
future earnings, future numbers of members or clients, litigation
outcomes, regulatory developments, market developments, new products and
growth strategies, and the effects of any of the foregoing on our future
results of operations or financial conditions.
Forward-looking statements are neither historical facts nor assurances
of future performance. Instead, they are based only on our current
beliefs, expectations and assumptions regarding the future of our
business, future plans and strategies, projections, anticipated events
and trends, the economy and other future conditions. Because
forward-looking statements relate to the future, they are subject to
inherent uncertainties, risks and changes in circumstances that are
difficult to predict and many of which are outside of our control. Our
actual results and financial condition may differ materially from those
indicated in the forward-looking statements. Therefore, you should not
rely on any of these forward-looking statements. Important factors that
could cause our actual results and financial condition to differ
materially from those indicated in the forward-looking statements
include, among others, the following: (i) changes in laws and
regulations applicable to our business model; (ii) changes in market
conditions and receptivity to our services and offerings; (iii) results
of litigation; (iv) the loss of one or more key clients; and (v) changes
to our abilities to recruit and retain qualified providers into our
network. Additional relevant risks that may affect our results are
described in certain of our filings with the Securities and Exchange
Commission.
Any forward-looking statement made by us in this press release is based
only on information currently available to us and speaks only as of the
date on which it is made. We undertake no obligation to publicly update
any forward-looking statement, whether written or oral, that may be made
from time to time, whether as a result of new information, future
developments or otherwise.
|
|
|
|
|
|
|
CONSOLIDATED BALANCE SHEETS
|
(In thousands, except share and per share data , unaudited)
|
|
|
|
|
|
|
|
September 30,
|
|
December 31,
|
|
|
2015
|
|
2014
|
|
|
|
|
|
|
Assets
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
54,064
|
|
|
$
|
46,436
|
|
Short-term investments
|
|
|
97,934
|
|
|
|
—
|
|
Accounts receivable, net of allowance of $1,267 and $1,785,
respectively
|
|
|
9,370
|
|
|
|
6,839
|
|
Due from officer
|
|
|
—
|
|
|
|
253
|
|
Prepaid expenses and other current assets
|
|
|
2,547
|
|
|
|
1,122
|
|
Deferred taxes
|
|
|
33
|
|
|
|
12
|
|
Total current assets
|
|
|
163,948
|
|
|
|
54,662
|
|
Property and equipment, net
|
|
|
5,852
|
|
|
|
1,065
|
|
Goodwill
|
|
|
56,342
|
|
|
|
28,454
|
|
Intangible assets, net
|
|
|
16,854
|
|
|
|
7,530
|
|
Other assets
|
|
|
284
|
|
|
|
296
|
|
Total assets
|
|
$
|
243,280
|
|
|
$
|
92,007
|
|
Liabilities, convertible preferred stock and stockholders’ equity
(deficit)
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
2,056
|
|
|
$
|
2,210
|
|
Accrued expenses and other current liabilities
|
|
|
8,045
|
|
|
|
3,918
|
|
Accrued compensation
|
|
|
5,956
|
|
|
|
3,358
|
|
Long-term bank and other debt-current portion
|
|
|
1,250
|
|
|
|
833
|
|
Total current liabilities
|
|
|
17,307
|
|
|
|
10,319
|
|
Other liabilities
|
|
|
6,517
|
|
|
|
2,767
|
|
Deferred taxes
|
|
|
1,056
|
|
|
|
494
|
|
Long term bank and other debt
|
|
|
25,863
|
|
|
|
25,196
|
|
Commitments and contingencies
|
|
|
|
|
|
|
Convertible preferred stock, $0.001 par value; 50,479,286 shares
authorized as of September 30, 2015 and December 31, 2014; no shares
issued and outstanding as of September 30, 2015 and 50,452,939
shares issued and outstanding as of December 31, 2014; liquidation
preference of $117,914 as of December 31, 2014
|
|
|
—
|
|
|
|
117,914
|
|
Redeemable common stock, $0.001 par value; no shares issued or
outstanding as of September 30, 2015 and 113,294 shares issued and
outstanding as of December 31, 2014
|
|
|
—
|
|
|
|
2,852
|
|
Stockholders’ equity (deficit):
|
|
|
|
|
|
|
Common stock, $0.001 par value; 75,000,000 shares authorized as of
September 30, 2015 and December 31, 2014; 38,441,130 shares and
2,037,999 shares issued and outstanding as of September 30, 2015 and
December 31, 2014
|
|
|
38
|
|
|
|
2
|
|
Additional paid-in capital
|
|
|
307,998
|
|
|
|
4,953
|
|
Accumulated deficit
|
|
|
(115,503
|
)
|
|
|
(72,490
|
)
|
Accumulated other comprehensive income
|
|
|
4
|
|
|
|
—
|
|
Total stockholders’ equity (deficit)
|
|
|
192,537
|
|
|
|
(67,535
|
)
|
Total liabilities, convertible preferred stock and stockholders’
equity (deficit)
|
|
$
|
243,280
|
|
|
$
|
92,007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CONSOLIDATED STATEMENTS OF OPERATIONS
|
(In thousands, except share and per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarters Ended September 30,
|
|
Nine Months Ended September 30,
|
|
|
2015
|
|
2014
|
|
2015
|
|
2014
|
Revenue
|
|
$
|
19,973
|
|
|
$
|
10,905
|
|
|
$
|
54,745
|
|
|
$
|
30,601
|
|
Cost of revenue
|
|
|
4,488
|
|
|
|
2,151
|
|
|
|
14,563
|
|
|
|
6,160
|
|
Gross profit
|
|
|
15,485
|
|
|
|
8,754
|
|
|
|
40,182
|
|
|
|
24,441
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Advertising and marketing
|
|
|
5,284
|
|
|
|
1,984
|
|
|
|
14,356
|
|
|
|
5,938
|
|
Sales
|
|
|
5,111
|
|
|
|
3,263
|
|
|
|
13,190
|
|
|
|
8,441
|
|
Technology and development
|
|
|
3,941
|
|
|
|
1,960
|
|
|
|
10,050
|
|
|
|
5,216
|
|
General and administrative
|
|
|
12,253
|
|
|
|
4,754
|
|
|
|
40,708
|
|
|
|
12,131
|
|
Depreciation and amortization
|
|
|
1,491
|
|
|
|
650
|
|
|
|
3,317
|
|
|
|
1,618
|
|
Loss from operations
|
|
|
(12,595
|
)
|
|
|
(3,857
|
)
|
|
|
(41,439
|
)
|
|
|
(8,903
|
)
|
Interest (expense), net
|
|
|
(489
|
)
|
|
|
(510
|
)
|
|
|
(1,699
|
)
|
|
|
(914
|
)
|
Net loss before taxes
|
|
|
(13,084
|
)
|
|
|
(4,367
|
)
|
|
|
(43,138
|
)
|
|
|
(9,817
|
)
|
Income tax provision (benefit)
|
|
|
162
|
|
|
|
162
|
|
|
|
(125
|
)
|
|
|
227
|
|
Net loss
|
|
|
(13,246
|
)
|
|
|
(4,529
|
)
|
|
|
(43,013
|
)
|
|
|
(10,044
|
)
|
Preferred stock dividend
|
|
|
—
|
|
|
|
(834
|
)
|
|
|
—
|
|
|
|
(2,920
|
)
|
Accretion of preferred stock
|
|
|
—
|
|
|
|
(168
|
)
|
|
|
—
|
|
|
|
(168
|
)
|
Net loss available to common stockholders
|
|
$
|
(13,246
|
)
|
|
$
|
(5,531
|
)
|
|
$
|
(43,013
|
)
|
|
$
|
(13,132
|
)
|
Net loss per share, basic and diluted
|
|
$
|
(0.37
|
)
|
|
$
|
(2.68
|
)
|
|
$
|
(3.15
|
)
|
|
$
|
(7.21
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average shares used to compute basic and diluted net loss
per share
|
|
|
36,099,556
|
|
|
|
2,060,075
|
|
|
|
13,668,420
|
|
|
|
1,821,832
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pro forma net loss per share, basic and diluted
|
|
$
|
(0.35
|
)
|
|
|
|
|
$
|
(1.14
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average shares used to compute basic and diluted pro forma
net loss per share
|
|
|
38,378,118
|
|
|
|
|
|
|
37,600,271
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
(In thousands, unaudited)
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30,
|
|
|
2015
|
|
2014
|
Cash flows used in operating activities:
|
|
|
|
|
|
|
Net loss
|
|
$
|
(43,013
|
)
|
|
$
|
(10,044
|
)
|
Adjustments to reconcile net loss to net cash used in operating
activities:
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
3,317
|
|
|
|
1,618
|
|
Allowance for doubtful accounts
|
|
|
1,418
|
|
|
|
766
|
|
Stock-based compensation
|
|
|
2,096
|
|
|
|
428
|
|
Deferred income taxes
|
|
|
(125
|
)
|
|
|
227
|
|
Accretion of interest
|
|
|
241
|
|
|
|
67
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
Accounts receivable
|
|
|
(3,415
|
)
|
|
|
(3,851
|
)
|
Due from officer
|
|
|
253
|
|
|
|
—
|
|
Prepaid expenses and other current assets
|
|
|
(1,573
|
)
|
|
|
(76
|
)
|
Other assets
|
|
|
13
|
|
|
|
(83
|
)
|
Accounts payable
|
|
|
(769
|
)
|
|
|
508
|
|
Accrued expenses and other current liabilities
|
|
|
600
|
|
|
|
2,230
|
|
Accrued compensation
|
|
|
2,516
|
|
|
|
1,148
|
|
Other liabilities
|
|
|
4,064
|
|
|
|
(13
|
)
|
Net cash used in operating activities
|
|
|
(34,377
|
)
|
|
|
(7,075
|
)
|
Cash flows used in investing activities:
|
|
|
|
|
|
|
Purchase of property and equipment
|
|
|
(5,481
|
)
|
|
|
(736
|
)
|
Purchase of internal software
|
|
|
(1,174
|
)
|
|
|
(495
|
)
|
Purchase of marketable securities
|
|
|
(100,556
|
)
|
|
|
—
|
|
Proceeds from the liquidation/maturity of marketable securities
|
|
|
2,509
|
|
|
|
—
|
|
Acquisition of business, net of cash acquired
|
|
|
(17,767
|
)
|
|
|
(13,844
|
)
|
Net cash used in investing activities
|
|
|
(122,469
|
)
|
|
|
(15,075
|
)
|
Cash flows from financing activities:
|
|
|
|
|
|
|
Proceeds from the exercise of stock options and warrants
|
|
|
326
|
|
|
|
646
|
|
Proceeds from issuance of convertible preferred stock
|
|
|
—
|
|
|
|
50,082
|
|
Proceeds from borrowing under bank and other debt
|
|
|
6,800
|
|
|
|
19,700
|
|
Repayment of bank and other debt
|
|
|
(5,770
|
)
|
|
|
—
|
|
Proceeds from issuance of common stock under IPO
|
|
|
163,118
|
|
|
|
—
|
|
Net cash provided by financing activities
|
|
|
164,474
|
|
|
|
70,428
|
|
Net decrease in cash and cash equivalents
|
|
|
7,628
|
|
|
|
48,278
|
|
Cash and cash equivalents at beginning of year
|
|
|
46,436
|
|
|
|
3,212
|
|
Cash and cash equivalents at end of year
|
|
$
|
54,064
|
|
|
$
|
51,490
|
|
Interest paid:
|
|
$
|
1,368
|
|
|
$
|
534
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EBITDA Reconciliation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
|
|
September 30,
|
|
September 30,
|
|
|
2015
|
|
2014
|
|
2015
|
|
2014
|
|
|
(in thousands)
|
Net loss
|
|
$
|
(13,246
|
)
|
|
$
|
(4,529
|
)
|
|
$
|
(43,013
|
)
|
|
$
|
(10,044
|
)
|
Add (deduct):
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense, net
|
|
|
489
|
|
|
|
510
|
|
|
|
1,699
|
|
|
|
914
|
|
Provision for income taxes (benefit)
|
|
|
162
|
|
|
|
162
|
|
|
|
(125
|
)
|
|
|
227
|
|
Depreciation expense
|
|
|
317
|
|
|
|
95
|
|
|
|
746
|
|
|
|
225
|
|
Amortization expense
|
|
|
1,174
|
|
|
|
555
|
|
|
|
2,571
|
|
|
|
1,393
|
|
EBITDA
|
|
|
(11,104
|
)
|
|
|
(3,207
|
)
|
|
|
(38,122
|
)
|
|
|
(7,285
|
)
|
Stock-based compensation
|
|
|
719
|
|
|
|
118
|
|
|
|
2,096
|
|
|
|
428
|
|
Adjusted EBITDA
|
|
$
|
(10,385
|
)
|
|
$
|
(3,089
|
)
|
|
$
|
(36,026
|
)
|
|
$
|
(6,857
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EPS Reconciliation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in thousands, except share and per share data)
|
|
1Q14
|
|
2Q14
|
|
3Q14
|
|
4Q14
|
|
1Q15
|
|
2Q15
|
|
3Q15
|
GAAP Net loss
|
|
$
|
(2,314
|
)
|
|
$
|
(3,200
|
)
|
|
$
|
(4,529
|
)
|
|
$
|
(6,994
|
)
|
|
$
|
(12,703
|
)
|
|
$
|
(17,064
|
)
|
|
$
|
(13,246
|
)
|
Add (deduct):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock Dividends
|
|
|
(1,031
|
)
|
|
|
(1,055
|
)
|
|
|
(834
|
)
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
Accretion of preferred stock
|
|
|
—
|
|
|
|
—
|
|
|
|
(168
|
)
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
GAAP Net Loss
|
|
$
|
(3,345
|
)
|
|
$
|
(4,255
|
)
|
|
$
|
(5,531
|
)
|
|
$
|
(6,994
|
)
|
|
$
|
(12,703
|
)
|
|
$
|
(17,064
|
)
|
|
$
|
(13,246
|
)
|
GAAP Net Loss per Share
|
|
$
|
(2.35
|
)
|
|
$
|
(2.15
|
)
|
|
$
|
(2.68
|
)
|
|
$
|
(3.25
|
)
|
|
$
|
(5.87
|
)
|
|
$
|
(7.20
|
)
|
|
$
|
(0.37
|
)
|
Weighted Average Common Shares Outstanding Used in Computing GAAP
Net Loss per Share - Basic and Diluted
|
|
|
1,423,732
|
|
|
|
1,974,697
|
|
|
|
2,060,075
|
|
|
|
2,150,228
|
|
|
|
2,162,413
|
|
|
|
2,370,113
|
|
|
|
36,099,556
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
![](http://cts.businesswire.com/ct/CT?id=bwnews&sty=20151102006641r1&sid=ntxv4&distro=nx&lang=en)
View source version on businesswire.com: http://www.businesswire.com/news/home/20151102006641/en/
Copyright Business Wire 2015